Seeing Is Believing
with an average price target of $113.06. This is a potential upside of $111 (5388.35%) from yesterday's end of day stock price of $2.06.
Indaptus Therapeutics's activity chart (see below) currently has 6 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 75 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 16-Oct-2024. First documented stock forecast 28-Feb-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jan-2022
$336
1 years 4 months 14 days ago
(16-Oct-2024)
0/3 (0%)
$262.71 (358.45%)
Buy Since 20-Oct-2021
$448
2 years 11 months 10 days ago
(20-Mar-2023)
0/1 (0%)
$225.96 (101.77%)
Buy Since 28-Feb-2018
$364
$361.94 (17569.90%)
$420
5 years 2 months 21 days ago
(09-Dec-2020)
2/2 (100%)
$-155.68 (-29.96%)
225
What is INDP (Indaptus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?
Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?
Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?